Journal of Hebei Medical College for Continuing Education ›› 2020, Vol. 37 ›› Issue (5): 36-49.DOI: 10.3969/j.issn.1674-490X.2020.05.006
Previous Articles Next Articles
Received:
2020-08-28
Online:
2020-10-25
Published:
2020-10-25
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: //yxyjyjy.hbu.edu.cn/EN/10.3969/j.issn.1674-490X.2020.05.006
[1] 吴志忠,王玺,李国帅,等.中西医非手术治疗早期股骨头坏死研究进展[J].中医研究,2020,33(1):68-71. [2] AMANATULLAH D F, STRAUSS E J, DI CESARE P E. Current management options for osteonecrosis of the femoral head: part 1, diagnosis and nonoperative management[J]. American journal of orthopedics, 2011,40(9):E186-E192. [3] 李泰贤,陈志伟,王荣田,等.基于文献计量学分析中医药治疗股骨头坏死的研究现状[J].中国中医骨伤科杂志,2017,25(4):41-46. [4] MONT M A, SALEM H S, PIUZZI N S, et al. Nontraumatic osteonecrosis of the femoral head: where do we stand today?: a 5-year update[J]. The Journal of Bone and Joint Surgery, 2020, 102(12):1084-1099. DOI: 10.2106/jbjs.19.01271. [5] GUERADO E,CASO E. The physiopathology of avascular necrosis of the femoral head: an update[J]. Injury,2016,47:S16-S26. DOI:10.1016/S0020-1383(16)30835-X. [6] KUMAR M N, BELEHALLI P, RAMACHANDRA P, et al. PET/CT study of temporal variations in blood flow to the femoral head following low-energy fracture of the femoral neck[J]. Orthopedics(Online), 2014, 37(6):e563-e570. DOI: 10.3928/01477447-20140528-57. [7] WANG G, ZHANG C Q, SUN Y, et al. Changes in femoral head blood supply and vascular endothelial growth factor in rabbits with steroid-induced osteonecrosis[J]. J Int Med Res, 2010, 38(3):1060-1069. DOI: 10.1177/147323001003800333. [8] ZENG X S, ZHAN K, ZHANG L L, et al.The impact of high total cholesterol and high low-density lipoprotein on avascular necrosis of the femoral head in low-energy femoral neck fractures[J].J Orthop Surg Res,2017,12(1):30. DOI: 10.1186/s13018-017-0532-0. [9] 吴子健,何俊君,洪振强.阳和汤在骨伤科疾病治疗中的应用和基础研究进展[J].中医正骨,2017,29(4):39-41. [10] 黄泽灵,何俊君,施珊妮,等.基于Wnt/β-catenin信号通路探讨阳和汤对兔膝骨关节炎的影响[J].福建中医药,2020,51(3):60-63. [11] 刘晓,姜文荣.加味阳和汤治疗股骨头缺血性坏死54例分析[J].实用中医内科杂志,2004,18(1):36-37. [12] 樊启象,李彦民,张鑫,等.李彦民应用阳和汤加减治疗早期股骨头坏死验案1则[J].中医药导报,2020,26(3):112-113,118. [13] CUI Q, ZHANG Y L, MA Y H, et al. A network pharmacology approach to investigate the mechanism of Shuxuening injection in the treatment of ischemic stroke[J]. J Ethnopharmacol, 2020, 257:112891. DOI: 10.1016/j.jep.2020.112891. [14] ZHANG C, YANG F, CORNELIA R, et al.Hypoxia-inducible factor-1 is a positive regulator of Sox9 activity in femoral head osteonecrosis[J].Bone, 2011, 48(3):507-513. DOI: 10.1016/j.bone.2010.10.006. [15] 薛亮,白东昱.TNF-α基因多态性及缺氧对激素诱导性股骨头坏死的影响分析[J].中国实验诊断学,2018,22(8):1360-1364. [16] DENG S, DAI G, CHEN S, et al. Dexamethasone induces osteoblast apoptosis through ROS-PI3K-AKT/GSK3β signaling pathway[J]. Biomed Pharmacother, 2019, 110:602-608. DOI: 10.1016/j.biopha.2018.11.103. [17] ZHANG F,PENG W X,ZHANG J, et al.P53 and Parkin co-regulate mitophagy in bone marrow mesenchymal stem cells to promote the repair of early steroid-induced osteonecrosis of the femoral head[J]. Cell Death Dis,2020,11(1):42. DOI: 10.1038/s41419-020-2238-1. [18] YOUM Y S, LEE S Y, LEE S H.Apoptosis in the osteonecrosis of the femoral head[J].Clin Orthop Surg, 2010, 2(4):250-255.DOI: 10.4055/cios.2010.2.4.250. [19] MAES C, ARALDI E, HAIGH K, et al.VEGF-independent cellautonomous functions of HIF-1alpha regulating oxygen consumption in fetal cartilage are critical for chondrocyte survival[J].J Bone Miner Res, 2012, 27(3):596-609. DOI: 10.1002/jbmr.1487. [20] DREYER C H, KJAERGAARD K, DIMG M, et al. Vascular endothelial growth factor for in vivo bone formation: a systematic review[J]. J Orthop Transl, 2020, 24:46-57. DOI: 10.1016/j.jot.2020.05.005. [21] DAILIANA E H, STEFANOU N, KHALDI L, et al.Vascular endothelial growth factor for the treatment of femoral head osteonecrosis: an experimental study in canines[J].World J Orthop,2018,9(9):120-129. [22] 韦寿锋,张传阳,张琼,等.炎症因子和血管内皮生长因子在骨搬移治疗大鼠感染性骨缺损中的变化情况[J].实用医学杂志,2020,36(7):885-889. [23] YU H C, YUE J A, WANG W G, et al. Icariin promotes angiogenesis in glucocorticoid-induced osteonecrosis of femoral heads: In vitro and in vivo studies[J]. J Cell Mol Med, 2019, 23(11):7320-7330. DOI: 10.1111/jcmm.14589. [24] 侯婧瑛,于萌蕾,郭天柱,等.缺氧预处理激活HIF-1α/MALAT1/VEGFA通路促进骨髓间充质干细胞生存和血管再生[J].中国组织工程研究,2021,25(7):985-990. [25] GARCIA P,SPEIDEL V,SCHEUER C,et al. Low dose erythropoietin stimulates bone healing in mice[J]. J Orthop Res, 2011, 29(2):165-172. DOI: 10.1002/jor.21219. [26] SHIOZAWA Y, JUNG Y, ZIEGLER A M, et al. Erythropoietin couples hematopoiesis with bone formation[J]. PLoS one, 2010, 5(5):e10853. DOI: 10.1371/journal.pone.0010853. [27] 潘书涵,王永萍,王茂林,等.基于TNF-α-HIF-1α-iNOS-NO信号通路探讨虎杖大黄素干预类风湿关节炎的作用研究[J].中药药理与临床,2019,35(4):62-67. [28] KIM H K,BIAN H,AYA-AY J,et al.Hypoxia and HIF-1a expression in the epiphyseal cartilage following ischemic injury to the immature femoral head[J].Bone,2009,45(2):280-288. DOI: 10.1016/j.bone.2009.03.665. [29] DING H,GAO Y S,HU C,et al.HIF-1alpha transgenic bone marrow cells can promote tissue repair in cases of corticosteroid-induced osteonecrosis of the femoral head in rabbits[J].PLoS One,2013,8(5):e63628. DOI: 10.1371/journal.pone.0063628. [30] 宋世雷,陈跃平,章晓云.PI3K-AKT信号通路调控股骨头坏死的相关机制[J].中国组织工程研究,2020,24(3):408-415. [31] GU Y X, DU J, SI M S, et al.The roles of PI3K-Akt signaling pathway in regulating MC3T3-E1 preoste and differentiation on SLA and SLActive titanium surfaces[J].J Biomed Mater Res, 2013, 101A(3):748-754. DOI: 10.1002/jbm.a.34377. [32] YUAN F L, XU R S, JIANG D L, et al. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhib iting the NF-κB and PI3K-Akt signaling pathways[J]. Bone,2015,75:128-137. DOI: 10.1016/j.bone.2015.02.017. [33] DUAN L,REN Y J. Role of notch signaling in osteoimmunology-from the standpoint of osteoclast differentiation[J]. The Eur J of Orthod, 2013, 35(2):175-182. DOI: 10.1093/ejo/cjs002. |
[1] | . [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(5): 38-45. |
[2] | . [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(5): 46-52. |
[3] | . [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(4): 37-40. |
[4] | . [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(4): 41-44. |
[5] | . [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(3): 55-60. |
[6] | . [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(2): 44-51. |
[7] | . [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(2): 52-57. |
[8] | . [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(1): 40-45. |
[9] | . [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(6): 1-8. |
[10] | . [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(6): 37-43. |
[11] | . [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(6): 44-52. |
[12] | . [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(6): 53-57. |
[13] | MA Xiaoli, WANG Hu, LIANG Cuiyun, ZHANG Yi. Advances on the enrichment of heavy metals in traditional Chinese medicine [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(5): 31-38. |
[14] | MENG Hongwei. YIN Sizhen's experience in gynecology [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(5): 39-48. |
[15] | MENG Hongwei. HAO's clinical experience of traditional Chinese medicine in Baoding in ophthalmology [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(4): 45-54. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||